Spots Global Cancer Trial Database for epilepsy
Every month we try and update this database with for epilepsy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Neuronal and Network Mechanisms of Electrocortical Stimulation | NCT06391294 | Epilepsy Brain Tumor Adu... | 18 Years - 80 Years | Northwestern University | ||
Brain Representation of Acquisition in Humans of Motor-Sensory Skills | NCT05688683 | Epilepsy Cerebral Tumor | use of a therem... | 18 Years - | Fondation Ophtalmologique Adolphe de Rothschild | |
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices | NCT02015806 | Cardiovascular ... Diabetes Breast Cancer Depression Mental Health D... Prostatic Hyper... Parkinson's Dis... Epilepsy | RxTimerCap Take-N-Slide Pillbox | 18 Years - 64 Years | Brigham and Women's Hospital | |
a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY | NCT04290611 | Prostate Cancer Neuropathy Epilepsy Encephalopathy | Enzalutamide | 18 Years - 100 Years | Groupe Hospitalier Pitie-Salpetriere | |
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery | NCT04344626 | Epilepsy Focal Cortical ... Tuberous Sclero... Hemimegalenceph... Polymicrogyria Rasmussen Encep... Sturge-Weber Sy... Gliosis Stroke Tumor, Brain | Intra-operative... | - | University of California, Los Angeles | |
Tumor Related Epilepsy | NCT02639325 | Epilepsy Cancer Brain Neoplasm | 8 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
Turmeric as Treatment in Epilepsy | NCT03254680 | Epilepsy Dravet Syndrome Lennox-Gastaut ... Tuberous Sclero... Focal Seizures | Turmeric | 1 Year - 70 Years | NYU Langone Health | |
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices | NCT02015806 | Cardiovascular ... Diabetes Breast Cancer Depression Mental Health D... Prostatic Hyper... Parkinson's Dis... Epilepsy | RxTimerCap Take-N-Slide Pillbox | 18 Years - 64 Years | Brigham and Women's Hospital | |
Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping? | NCT06040580 | Brain Tumor Brain Pathology Epilepsy Vascular Malfor... | - | Universitaire Ziekenhuizen KU Leuven | ||
PatientSpot Formerly Known as ArthritisPower | NCT03840928 | Rheumatoid Arth... Ankylosing Spon... Fibromyalgia Gout Crohn Disease Juvenile Idiopa... Lupus Erythemat... Myositis Osteoarthritis Osteoporosis Psoriasis Psoriatic Arthr... Scleroderma Dermatomyositis Inflammatory Bo... Polymyositis Axial Spondyloa... Diffuse Idiopat... Polymyalgia Rhe... Giant Cell Arte... Temporal Arteri... Wegener Relapsing Polyc... Undifferentiate... Spinal Cord Inj... Alzheimer Disea... Amyotrophic Lat... Ataxia Bell Palsy Brain Tumor Cerebral Aneury... Epilepsy Guillain-Barre ... Headache Head Injury Hydrocephalus Lumbar Disc Dis... Meningitis Multiple Sclero... Muscular Dystro... Neurocutaneous ... Parkinson Disea... Stroke Cluster Headach... Tension-Type He... Chronic Obstruc... Asthma Lung Cancer Cystic Fibrosis Sleep Apnea Eczema Alopecia Chronic Inflamm... Unstable Angina Heart Attack Heart Failure Arrythmia Valve Heart Dis... High Blood Pres... Congenital Hear... Peripheral Arte... Diabetes Chronic Liver D... Obesity | 19 Years - | Global Healthy Living Foundation | ||
A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization | NCT03685630 | Partial Seizure... Epilepsy | Brivaracetam | 16 Years - | UCB Pharma | |
Real World Evidence on the Use of Medical Cannabis in Pediatrics | NCT05863910 | Cancer Epilepsy Neurodevelopmen... | Medical Cannabi... | 3 Years - 17 Years | University of Manitoba | |
A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy | NCT03083665 | Partial Seizure... Epilepsy | Placebo Brivaracetam | 16 Years - 80 Years | UCB Pharma | |
Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare Diseases | NCT05199402 | Tuberous Sclero... Epilepsy | 4 Months - 2 Years | Imagine Institute | ||
Epilepsy-related Brain Tumors Register | NCT03876093 | Epilepsy | 18 Years - | Fondation Hôpital Saint-Joseph | ||
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy | NCT00454935 | Epilepsy Glioma | 18 Years - | Amsterdam UMC, location VUmc | ||
Diffusion MRI-1 Imaging Database | NCT03775694 | Epilepsy Tumor Healthy Other | dMRI Scan | - | Medtronic Spinal and Biologics | |
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD | NCT02451696 | Epilepsy Tuberous Sclero... Focal Cortical ... | Everolimus | 2 Years - 40 Years | NYU Langone Health | |
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC | NCT01767779 | Tuberous Sclero... | 1 Day - 6 Months | University of Alabama at Birmingham | ||
JASPER Early Intervention for Tuberous Sclerosis | NCT03422367 | Tuberous Sclero... | JASPER | 6 Months - 40 Months | University of California, Los Angeles | |
The Management of Postoperative Craniotomy Pain in Pediatric Patients | NCT01576601 | Post Craniotomy... Cancer Epilepsy Vascular Malfor... Craniofacial Re... | - 18 Years | Johns Hopkins University | ||
Turmeric as Treatment in Epilepsy | NCT03254680 | Epilepsy Dravet Syndrome Lennox-Gastaut ... Tuberous Sclero... Focal Seizures | Turmeric | 1 Year - 70 Years | NYU Langone Health | |
The Management of Postoperative Craniotomy Pain in Pediatric Patients | NCT01576601 | Post Craniotomy... Cancer Epilepsy Vascular Malfor... Craniofacial Re... | - 18 Years | Johns Hopkins University | ||
Use of the Atkins Diet for Children With Sturge Weber Syndrome | NCT00639730 | Epilepsy Sturge Weber Sy... | modified Atkins... | 2 Years - 18 Years | Johns Hopkins University | |
Quality Improvement and Practice Based Research in Neurology Using the EMR | NCT02670161 | Brain Tumors Epilepsy Migraine Mild Cognitive ... Concussion Multiple Sclero... Neuropathy Parkinson's Restless Legs S... Stroke | Listed for each... | 18 Years - 100 Years | NorthShore University HealthSystem | |
Tumor Related Epilepsy | NCT02639325 | Epilepsy Cancer Brain Neoplasm | 8 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
Epilepsy-related Brain Tumors Register | NCT03876093 | Epilepsy | 18 Years - | Fondation Hôpital Saint-Joseph | ||
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
High-density EEG in Neurological Disorders | NCT04266041 | Epilepsy Tumor Healthy | High-density el... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study | NCT05104983 | Tuberous Sclero... Epilepsy | Sirolimus Placebo | 1 Day - 6 Months | Children's Hospital Medical Center, Cincinnati | |
Glioma Intraoperative MicroElectroCorticoGraphy | NCT06408428 | Glioma Epilepsy | PANAXIUM MicroE... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
Integrative and Complementary Health Practices (PICS) | NCT04152109 | Neoplasms Epilepsy | Without laying ... Laying on of ha... Laying on of ha... | 18 Years - | Universidade Federal do Triangulo Mineiro | |
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | NCT05638269 | Essential Hyper... Liver Cancer Nasopharyngeal ... Pancreatic Canc... Lung Cancer Chronic Kidney ... Acute Coronary ... Epilepsy Gastric Cancer Primary Aldoste... Subclinical hyp... | no intervention | 18 Years - 75 Years | Zhujiang Hospital | |
The Effectiveness and Safety of Vagus Nerve Stimulation for TRE | NCT04198207 | Tuberous Sclero... Epilepsy | 2 Years - | Beijing Children's Hospital | ||
Recording High Frequency Oscillations in Patients With Tumors and Epilepsy | NCT02320136 | Epilepsy Tumor | cognitive testi... | 18 Years - 99 Years | University of Zurich | |
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants | NCT04595513 | Tuberous Sclero... Epilepsy | TAVT-18 (siroli... | 1 Day - 6 Months | Children's Hospital Medical Center, Cincinnati | |
A Complex Contraception Registry | NCT02219269 | Diabetes Cardiovascular ... Epilepsy Migraine Neurological Di... Cancer Bariatric Surge... Organ or Tissue... Lupus Erythemat... Other Hematolog... Other Venous Em... | 18 Years - 45 Years | University of California, San Diego | ||
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise? | NCT06251830 | Neurodevelopmen... Neurodegenerati... Brain Tumor Multiple Sclero... Epilepsy | MRI exam with M... | 4 Years - | IRCCS Fondazione Stella Maris | |
Digital Outpatient Services | NCT05068869 | Epilepsy Cancer Interstitial Lu... Long Term Pain | Dignio Digital ... Usual Care Cont... | 18 Years - | Oslo University Hospital | |
Recording High Frequency Oscillations in Patients With Tumors and Epilepsy | NCT02320136 | Epilepsy Tumor | cognitive testi... | 18 Years - 99 Years | University of Zurich | |
Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping? | NCT06040580 | Brain Tumor Brain Pathology Epilepsy Vascular Malfor... | - | Universitaire Ziekenhuizen KU Leuven | ||
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD | NCT02451696 | Epilepsy Tuberous Sclero... Focal Cortical ... | Everolimus | 2 Years - 40 Years | NYU Langone Health | |
Quality Improvement and Practice Based Research in Neurology Using the EMR | NCT02670161 | Brain Tumors Epilepsy Migraine Mild Cognitive ... Concussion Multiple Sclero... Neuropathy Parkinson's Restless Legs S... Stroke | Listed for each... | 18 Years - 100 Years | NorthShore University HealthSystem | |
Glioma Intraoperative MicroElectroCorticoGraphy | NCT06408428 | Glioma Epilepsy | PANAXIUM MicroE... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization | NCT03685630 | Partial Seizure... Epilepsy | Brivaracetam | 16 Years - | UCB Pharma | |
A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization | NCT03250377 | Partial Seizure... Epilepsy | Brivaracetam | 16 Years - | UCB Pharma | |
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex | NCT03356769 | Tuberous Sclero... Aspirin Epilepsy Cognitive Decli... Skin Lesions | Aspirin AED Placebo | 6 Years - 30 Years | Peking Union Medical College Hospital | |
Turmeric as Treatment in Epilepsy | NCT03254680 | Epilepsy Dravet Syndrome Lennox-Gastaut ... Tuberous Sclero... Focal Seizures | Turmeric | 1 Year - 70 Years | NYU Langone Health | |
A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients | NCT00952081 | Hypertension Brain Tumor Epilepsy | Clevidipine | 21 Years - | NYU Langone Health | |
JASPER Early Intervention for Tuberous Sclerosis | NCT03422367 | Tuberous Sclero... | JASPER | 6 Months - 40 Months | University of California, Los Angeles | |
Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors | NCT02276053 | Brain Tumor Rel... | 16 Years - | UCB Pharma | ||
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | NCT05638269 | Essential Hyper... Liver Cancer Nasopharyngeal ... Pancreatic Canc... Lung Cancer Chronic Kidney ... Acute Coronary ... Epilepsy Gastric Cancer Primary Aldoste... Subclinical hyp... | no intervention | 18 Years - 75 Years | Zhujiang Hospital | |
Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex | NCT02098759 | TSC Tuberous Sclero... Epilepsy | epilepsy early ... | - 4 Months | Children's Memorial Health Institute, Poland | |
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy | NCT04076449 | Cavernous Malfo... Cavernous Angio... Cavernous Heman... Cavernous Heman... Seizures Seizures, Epile... Epilepsy | 18 Years - 70 Years | Beijing Tiantan Hospital | ||
Real World Evidence on the Use of Medical Cannabis in Pediatrics | NCT05863910 | Cancer Epilepsy Neurodevelopmen... | Medical Cannabi... | 3 Years - 17 Years | University of Manitoba | |
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex | NCT03356769 | Tuberous Sclero... Aspirin Epilepsy Cognitive Decli... Skin Lesions | Aspirin AED Placebo | 6 Years - 30 Years | Peking Union Medical College Hospital | |
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC | NCT01767779 | Tuberous Sclero... | 1 Day - 6 Months | University of Alabama at Birmingham | ||
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery | NCT04344626 | Epilepsy Focal Cortical ... Tuberous Sclero... Hemimegalenceph... Polymicrogyria Rasmussen Encep... Sturge-Weber Sy... Gliosis Stroke Tumor, Brain | Intra-operative... | - | University of California, Los Angeles | |
Glutamate Inhibitors in Glioblastoma | NCT05664464 | Glioblastoma | Gabapentin Sulfasalazine Memantine Temozolomide Radiotherapy | 18 Years - | University of Zurich | |
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy | NCT04076449 | Cavernous Malfo... Cavernous Angio... Cavernous Heman... Cavernous Heman... Seizures Seizures, Epile... Epilepsy | 18 Years - 70 Years | Beijing Tiantan Hospital | ||
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study | NCT05104983 | Tuberous Sclero... Epilepsy | Sirolimus Placebo | 1 Day - 6 Months | Children's Hospital Medical Center, Cincinnati | |
Evaluation and Treatment of Neurosurgical Disorders | NCT00060541 | Neurologic Diso... | Laboratory test... Radiological ex... | 4 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries | NCT05819008 | Traumatic Brain... Stroke Multiple Sclero... Parkinson Disea... Epilepsy Brain Tumor | Neuropsychologi... | 18 Years - | Umeå University | |
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures | NCT04485104 | Seizure in Part... Seizure in Part... Seizure in Part... | GWP42003-P | 1 Month - 23 Months | Jazz Pharmaceuticals | |
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy | NCT00454935 | Epilepsy Glioma | 18 Years - | Amsterdam UMC, location VUmc | ||
EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality | NCT03987633 | Atrial Fibrilla... Coronary Heart ... Cardiovascular ... Heart Failure Hypertension Peripheral Arte... Stroke, Ischemi... Asthma Chronic Obstruc... Obesity Cancer Chronic Kidney ... Diabetes Mellit... Dementia Depression Epilepsy Mental Health D... Rheumatoid Arth... Blood Pressure | 6 Years - | Future Genetics Limited | ||
Cancer in Patients With Gabapentin (GPRD) | NCT01236053 | Pain, Neuropath... Epilepsy Renal Pelvis Ca... Pancreatic Canc... Breast Cancer Nervous System ... Chronic Pancrea... Stomach Cancer Renal Cell Carc... Diabetes Bladder Cancer Bone and Joint ... Penis Cancer Anal Cancer Cancer Renal Cancer | Gabapentin pres... | - | GlaxoSmithKline | |
The Neural Code and Dynamics of the Reading Network. | NCT05989893 | Epilepsy Brain Tumor | Language-based ... | 18 Years - 75 Years | The University of Texas Health Science Center, Houston | |
The Management of Postoperative Craniotomy Pain in Pediatric Patients | NCT01576601 | Post Craniotomy... Cancer Epilepsy Vascular Malfor... Craniofacial Re... | - 18 Years | Johns Hopkins University | ||
Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas | NCT05029960 | Brain Tumor | Brivaracetam | 18 Years - | University of Rochester | |
A Complex Contraception Registry | NCT02219269 | Diabetes Cardiovascular ... Epilepsy Migraine Neurological Di... Cancer Bariatric Surge... Organ or Tissue... Lupus Erythemat... Other Hematolog... Other Venous Em... | 18 Years - 45 Years | University of California, San Diego | ||
Functional Organization of the Superior Temporal Gyrus for Speech Perception | NCT05435859 | Epilepsy Brain Tumor Speech | Speech Tasks | 18 Years - 70 Years | University of California, San Francisco | |
The Neural Code and Dynamics of the Reading Network. | NCT05989893 | Epilepsy Brain Tumor | Language-based ... | 18 Years - 75 Years | The University of Texas Health Science Center, Houston | |
Connectivity Alterations After Levetiracetam Application | NCT04425798 | Glioma Epilepsy | 18 Years - 75 Years | Beijing Neurosurgical Institute |